![](https://investorshub.advfn.com/uicon/19649.png?cb=1607617291)
Thursday, May 20, 2021 3:28:44 AM
I just read an article appearing on the internet site, India dot tv, that the Hospital Chairperson of Ganga Ram Hospital in New Delhi, Dr. DS Rana, has said that they are considering dropping Remdesivir as a COVID therapeutic/treatment as, “...there is no evidence of its effectiveness in treating COVID patients.”
https://www.indiatvnews.com/news/india/remdesivir-may-be-dropped-soon-as-there-is-no-proof-of-its-effectiveness-in-treating-covid19-patients-705500
While we already knew this, it further affirms the direction the NIH, FDA, EMA, actual hospital physicians in other countries, (et al) are taking with regard to Aviptadil’s/Zyesami’s future COVID indications.
I am truly of the opinion, as I know many of you are, that Aviptadil/Zyesami WILL become SOC for COVID, and MANY other respiratory ailments, in the US, Europe, their allied countries, and SO MANY other places around the globe.
It’s only a matter of time at this point, as Remdesivir continues to show limited, to no, efficacy against COVID.
We’re going “Prime Time” before you know it. Stay Long and Strong...it’s coming!
—Cheers to All—
~ Money Making Money ~
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM